Showing 331 - 340 of 696 for "Investment%20funds" with applied filters
15 September 2023 by
From January 2023 to now, AnJie Broad has recruited Mr. Keyu CAO, Mr. Zhining Wang, Mr. Mingqing Zhao, Mr. Kevin TSEN, Ms. Yolanda ZHANG, Ms. Yanyan DENG, Mr. Heng KUANG, Ms. Xueping WEI, Mr. Mark YANG, Mr. Min DING, to join the Firm as partners, and has also internally promoted Ms. Shanshan WU, Ms. Kaiying XU, Ms. Yue MA, Ms. Jingjing CAI, Mr. Xingchao HUANG, Mr. Danyang XIANG to become partners.
15 September 2023 by
Yuen Law has been shortlisted as finalist for the prestigious Regulatory Law Firm of the Year award at the Asian Legal Business (ALB) Pan Asian Regulatory Summit Awards 2023/2024.
07 September 2023 by
September 07, 2023: We are delighted to announce that Chennai-based law firm Commercial Law Advisors (“CLA”) will be merging with JSA with effect from 1 October 2023.
29 August 2023 by
The Korean Ministry of Economy and Finance (MOEF) confirmed and announced the FY2023 tax law amendment proposals on July 27, 2023 (Proposals).
27 July 2023 by
With significant development in dietary supplements and alternative food industry in recent years, Korean government announced alternative food (e.g., plant-based meet, cultured meat, insect based meat, etc.), dietary supplement and medical food (i.e., specially formulated food for patients with certain symptoms or nutritional needs) as industry sectors for future development.
24 July 2023 by
A proposal for partial amendment (Amendment) to the Financial Investment Services and Capital Markets Act (FISCMA) for the purpose of strengthening the regulation of unfair trading passed the plenary session of the National Assembly of Korea on June 30, 2023 and was promulgated on July 18, 2023.
17 July 2023 by
The Hong Kong Dollar (HKD)-Renminbi (RMB) Dual Counter Model was launched in the Hong Kong stock market on 19 June 2023. The first batch covers 24 companies which already have their shares listed on the Main Board of the Hong Kong Stock Exchange and traded in HKD.
11 July 2023 by
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
03 July 2023 by
For several years, patent owners navigated the SEP landscape in India, unsure of their destination (injunction, damages, FRAND verdicts), and wondering whether their opponents (implementers of SEPs) could be made to deposit security, to protect the SEP owners’ interests.
25 May 2023 by
Kim & Chang, using separate teams, advised both the buyer, MBK Partners, and the sellers, UCK Partners (formerly known as Unison Capital Korea) and individual shareholders, in connection with the purchase and sale of Medit Corporation (the “Target Company”).
